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Abstract
Background: In recent years, incidences of thyroid cancer have increased in developed countries; one of the
known risk factors for thyroid cancer is exposure to radioiodine. Previous research by Bowlt and Tiplady [5] has
shown an inverse link between radioactive iodine levels contained in thyroid tissue of deceased inhabitants and the
distance they lived from the Sellafield nuclear facility in Cumbria, UK.
Objectives: The present study aimed to determine what thyroid cancer incidences were in the regional localities
in Cumbria for the last decade.
Methods: An ethics-approved retrospective cohort study in which age-standardised incidence of thyroid cancer
per 100,000 population was compared between localities within Cumbria and with UK average figures.
Conclusions: The present study shows that the apparent lower incidence of thyroid cancer in West Cumbria has
persisted, although due to the limited number of thyroid cancers diagnosed, a statistically significant difference was
not observed. Further research – potentially involving populations living near sources of radioiodine emission - is
indicated to investigate if there are any mechanisms that underlie this apparent trend.
Keywords Thyroid cancer; Epidemiology; Incidence; Radioiodine;
Radiation homeostasis; Radiation hormesis
Introduction
Thyroid cancer is the 18th (UK) and 5th (US) most common cancer
in women and the 20th most common cancer in men in the UK [1,2].
Treatment usually involves surgical removal of the thyroid and long-
term treatment with levothyroxine. The incidence of thyroid cancer
has increased by as much as 69% over the last decade, and a total of
2,727 new cases were diagnosed in the UK during 2011 [2]. This recent
increase in incidence is at least partly due to improved diagnostics.
However, another important factor may be the growing popularity of a
ͣWesternͤ diet high in fat and sugar. A recent study has linked obesity
to an elevated risk of thyroid cancer in women, although a similar
association was not seen in men [3]. Adequate intake of iodine is
essential to human health and development, and small quantities
obtained from the diet are actively concentrated within the thyroid
gland. For these reasons, exposure to the radioactive iodine isotopes
129I and 131I is an important risk factor for the development of
thyroid cancer. The effect of exposure to very high doses of
radioiodine has been demonstrated clearly following the Chernobyl
nuclear accident in 1986. Children from the most highly contaminated
regions of Ukraine, Belarus and Russia were shown to have a 7 to 9-
fold increase in their risk of thyroid cancer [4].
The health effect of lower doses of radioiodine is less clear. Data
from between 1969 and 1986 have shown an incidence of thyroid
cancer in the districts of Copeland and Allerdale in Cumbria, UK, that
is below the national average [5,6]. This was despite an increased
exposure to radioactive 129I discharged from the Sellafield nuclear
facility and measured in tissue samples from deceased Cumbrians [5].
More recent environmental data published by Sellafield Ltd. confirms
that measurable levels of I129 and I131 continued to be released by the
facility over the last decade, although these levels are considered to be
within safe limits [7]. This increased environmental exposure
occurring over decades, combined with the effect of fallout from
Chernobyl in 1986, means that the population of West Cumbria are of
particular interest regarding thyroid cancer risk. The aim of this
present study was to analyse new epidemiological data from the period
2003-2013 and to ascertain whether lower thyroid cancer incidence in
West Cumbria have persisted.
Methods
Study design and patients
This retrospective cohort study was reviewed and approved by
both the National Research Ethics Service (NRES), ref. 14/LO/1734
and the NHS Trust in which the research took place and the thyroid
cancer patients were diagnosed and treated. Any patient diagnosed
with thyroid cancer between the period 1 Jan 2003 and 31 Dec 2013
was included. Patients treated for thyroid cancer at West Cumberland
Hospital or Cumberland Infirmary, but being a resident outside the
four localities covered in this project (Carlisle, Eden Valley, Allerdale
and Copeland) were excluded from analysis.
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Statistical analysis
Data was collated in Microsoft Excel 2007, and further analysed
and interpreted using Excel and SPSS Statistical Package for Social
Sciences (SPSS) version 17.0 (SPSS Inc. Chicago, IL, USA, 2007).
Thyroid cancer cases were categorised by local authority. For each
locality, age-standardised incidence rates (with 95% confidence
intervals [CI]) were calculated using Office of National Statistics
methodology and the European Standard Population. Standard
quinary age distribution tables for Carlisle, Eden Valley, Allerdale and
Copeland for the year 2008 – midpoint for period covered - were
obtained from ONSOffice for National Statistics (ONS). UK age-
standardised incidence rates were taken from the year 2011 (http://
www.cancerresearchuk.org/cancer-info/cancerstats/types/thyroid/
mortality/uk-thyroid-cancer-mortality-statistics). Difference in age at
diagnosis between localities was assessed through one-way ANOVA
testing.
Results
A total of 124 patients were diagnosed with thyroid cancer between
2003-2013 in the four Cumbrian localities of Allerdale, Copeland,
Carlisle, and Eden Valley, included in this study. Table 1 shows age-
standardised incidence rates for thyroid cancer in said four different
Cumbrian localities and the for the UK. The youngest person to be
diagnosed with thyroid cancer in the period covered was 23 years of
age. Importantly, children were not included in this analysis because
they fall under the care of surgeons in a tertiary health centre in
Newcastle, rather than the local surgical team. The mean age at
diagnosis for patients in the different localities indicates a pattern that
suggests that thyroid cancer may occur earlier in life in West
Cumbrian patients. However, ANOVA analysis demonstrates that this
is a non-significant finding with the sample size (Table 2).
Locality Patients (n) Age-standardised incidence 95% CI
United Kingdom [ref 1] n/a 3.9 3.8 to 4.1
Allerdale 30 2.7 -0.5 to 5.8
Copeland 23 2.6 -0.9 to 6.2
Carlisle 42 3.1 0 to 6.2
Eden Valley 29 4.6 -1 to 10.1
Table 1: Age-standardised incidence rate (per 100,000) of thyroid cancer per locality.
Discussion
The relative rare incidence of thyroid cancer, compared to other
cancers such as prostate or breast cancer, means that this retrospective
cohort study has limited power to detect significant differences in
thyroid cancer incidence. Although the differences seen here are not
statistically significant, based on the reported 95% confidence interval
ratings, a lower age-standardised incidence rate for adults is seen for
the Copeland and Allerdale counties. These results mirror those
obtained by Bowlt and Tiplady, a few decades ago [5]. Following the
Chernobyl nuclear accident in 1986, there was a significant increase in
cases of thyroid cancer in young people in Cumbria as a whole [8].
Subsequent analysis demonstrated that the increased incidence was
primarily confined to female patients [9]. It should be noted that
ionising radiation fallout in Cumbria, originating from Chernobyl in
1986, was most concentrated in northern areas of the county around
Carlisle [9]. Taken together, there appear to be two patterns of thyroid
cancer incidence in Cumbria. One higher incidence rate involving
young people and potentially related to Chernobyl, and one lower
incidence rate involving adults – the focus of this study - which could
possibly related to very low dose radioactive iodine uptake in the
thyroid. Sellafield Ltd. discharges approximately 0.25 TBq (into Irish
Sea) and 9GBq (airborne) of 129I, and 0.45GBq (airborne) of 131I
each year [7]. Because of its longer half-life of 15.7 million years, 129I
would remain active in thyroids for the rest of a personͤs life if
ingested opposed to 131I with a half-life of eight days. The energy
activity levels of 131I are much higher than for 129I, produces far
more energy, 1.77×10-4 vs. 1.24×105 Ci/g.
Locality Sex (m/f) Mean age at diagnosis Median age at diagnosis 95% CI
Allerdale 6 / 24 51.6 52 47.0 to 56.2
Copeland 6 / 23 52.5 48 45.4 to 59.6
Carlisle 14 / 28 56.6 56.5 51.8 to 61.4
Eden Valley 6 / 23 54.1 54.0 47.6 to 60.5
p= 0.53 (one-way ANOVA)
Table 2: Patientsͤ demographics per locality.
If the linear non-threshold hypothesis for ionising radiation
exposure would apply, Bowlt and Tipladyͤs observation of an
increasing amount of 129I activity in thyroids from deceased people
living nearer to Sellafield would predict an increase in thyroid cancer
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in Allerdale and Copeland. The linear non-threshold (LNT)
hypothesis has been used to date when considering the damage that
ionising radiation may incur to humans. It implies that any dose of
ionising radiation is damaging and increases the risk of cancer [10].
Bowlt and Tipladyͤs data, together with the data presented in this
present study would imply a potential role for radiation hormesis (also
known as radiation homeostasis) induced by radioiodine, the
phenomenon where a very small dose of ionising radiation can excert
a protective effect [11,12].
The cellular mechanisms that underly radiation hormesis have
been studies extensively. Epigenetic changes take place in response to
(long-term) low dose radiation exposure, resulting in induction of a
term coined activated natural protection by Scott [13]. In essence, a
cluster of different cell defence mechanisms are activated to protect
cells and DNA in particular – examples include increased antioxidants,
activation of DNA repair genes, programmed cell death (apoptosis) of
irreversibly damaged cells, and modulation of inflammatory pathways
[13]. Taken together, these cellular processes have the potential to
reduce the risk of cells becoming cancerous. The support for the
radiation hormesis biomechanism appears to be getting stronger and
very recently Dr C S Marcus submitted a petition to the US Nuclear
Regulatory Commission to reject the LNT hypothesis [14]. In our
present purely epidemiological study we can only look at an
association rather than causation concerning the trend towards lower
thyroid cancer incidences in West Cumbria. Nevertheless, thyroid
cancer incidences do not appear to be increased despite patients in
Copeland and Allerdale living in the vicinity of the Sellafield nuclear
facility.
In West Cumbria, apart from higher levels of radioactive iodine
emission, another factor should theoretically contribute to higher
incidences of thyroid cancer. Copeland has the highest incidence in
the UK of overweight and obese adults [15]. This should theoretically
contribute to increased incidence of thyroid cancer – or at least
counteract any mechanism for decreased incidence because obesity
has been shown to contribute to an increase in thyroid cancer [3].
Other unidentified factors, not recognised due to the retrospective
cohort approach taken, could also contribute such as genetic factors.
Meanwhile, the incidence rate of other cancers, including colorectal
and breast cancer, has gone up considerably in Copeland in the last 10
years [15].
In conclusion, age-standardised thyroid cancer incidence rates in
West Cumbria are consistently lower – albeit not to statistically
significant lower levels - than in the rest of Cumbria and the national
UK average. Further work involving populations that live around
other nuclear facilities that emit radioactive iodine could give more
insight into the epidemiology of thyroid cancer and any potential
relationship with very low dose radioiodine exposure.
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